The Dawn of Hemodialysis: A Life-Saving Revolution

The development of the first successful artificial kidney stands as one of the most transformative events in modern medicine. Before its invention, acute kidney injury and end-stage renal disease were near-certain death sentences. Physicians could offer only supportive care while watching their patients succumb to uremic poisoning. The breakthrough that changed this grim reality emerged from the ingenuity and relentless determination of a single physician working under extraordinary conditions. This article traces the full arc of that historic achievement, from the earliest conceptual experiments to the clinical triumph that opened the door to dialysis as a standard therapy. More than 2.5 million people worldwide now depend on dialysis, a direct legacy of the pioneering work that began in a small Dutch town during World War II.

Early Attempts and Conceptual Foundations

Long before any workable device existed, the idea of filtering blood to remove waste products had captivated medical minds. In the mid-19th century, the Scottish chemist Thomas Graham laid the theoretical groundwork by describing the principle of dialysis — the diffusion of solutes across a semipermeable membrane. His experiments with parchment membranes and crystalloid solutions demonstrated that small molecules could be separated from larger ones, providing the scientific basis for all future artificial kidney designs. Graham's work on colloids and crystalloids earned him the title "father of colloid chemistry," and his insights would not be clinically applied for nearly a century.

First Steps Toward Blood Filtration

In 1913, American pharmacologists John Abel, Leonard Rowntree, and B.B. Turner built a device called a vividiffusion apparatus, using collodion tubes as the membrane. They successfully removed salicylate from the blood of anesthetized dogs, proving that extracorporeal blood purification was feasible. However, the apparatus required direct arteriovenous connection, had no reliable anticoagulant beyond crude hirudin, and could not be used for more than a few hours without causing severe clotting or infection. The team abandoned further development, but their proof-of-concept inspired others to pursue the challenge.

The Interwar Period: Incremental Progress

During the 1920s and 1930s, several European researchers refined the technology. Georg Haas in Germany performed the first human dialysis attempts in 1924 using purified hirudin (a leech-derived anticoagulant) and collodion tubes. He treated six patients with acute kidney failure, but only short sessions lasting 15 to 60 minutes were possible because the anticoagulant was weak and the membranes were prone to rupture. All patients died soon after treatment, and Haas eventually stopped his work due to technical limitations — particularly the lack of a safe, stable anticoagulant and the inability to prevent infection at the access site. The problems of reliable anticoagulation, infection control, and membrane biocompatibility remained unsolved. World War II would create the urgent clinical need — battlefield injuries causing crush syndrome and acute kidney failure — that finally drove the breakthrough.

The Breakthrough: Willem Kolff and the Rotating Drum Kidney

The name most closely linked to the first successful artificial kidney is Dr. Willem Johan Kolff, a Dutch physician who began his work in 1940, during the Nazi occupation of the Netherlands. Kolff had witnessed the death of a young man from kidney failure and became obsessed with finding a way to keep such patients alive. His resourcefulness under occupation — scavenging materials from local factories, using sausage casings as dialysis membranes, and even using the rotors of downed German airplanes for his machine — has become legendary in medical history. Kolff's approach was deeply pragmatic: he tested multiple membrane materials, including cellophane from commercial wrappers, and built his first rotating drum machine from scrap metal, an enamel bathtub, and a salvaged electric motor.

The Design of the Rotating Drum Kidney

Kolff’s prototype, built in the small town of Kampen, used a horizontal rotating drum wrapped with several dozen meters of cellophane tubing. The patient’s blood flowed through the tubing while the drum rotated through an upright bath of dialysate fluid. The rotation provided both a gentle pumping action and continuous exposure of blood to the cleansing solution. The entire machine was sterilized with formaldehyde, which was both a disinfectant and a preservative. Kolff used heparin (which had recently become commercially available in purified form) to prevent clotting during the procedure. The system was fragile, prone to leaks — blood would occasionally spray across the room — and required massive amounts of donor blood to prime the tubing, often up to 1.5 liters. Despite these drawbacks, the machine could remove urea, creatinine, and other uremic toxins with surprising efficiency for its era.

First Human Treatments: 1943

In March 1943, Kolff treated his first patient — a 29-year-old woman with progressive uremia from chronic kidney disease. The procedure lasted 11 hours and removed significant amounts of urea, but the patient died two days later from a cerebral hemorrhage, likely related to the heparin. Kolff’s second patient, a 67-year-old man with acute kidney injury after surgery, became the first human to survive temporary dialysis in a clinical sense — he regained kidney function and lived for another seven years. However, the machine was far from reliable. The first 15 patients all died, many from complications of the underlying disease rather than the dialysis itself. Patient number 17, a woman in uremic coma from acute pyelonephritis, regained consciousness during treatment and survived for several more years. This was the case that convinced Kolff and the wider medical community that the artificial kidney could genuinely save lives. Kolff later said, "I knew if I could get one patient to survive, the principle was established."

Refinements and Clinical Adoption

Kolff published his results in 1944 in a Dutch medical journal, but the war prevented any immediate dissemination. After the war, he donated machines to hospitals in London, Boston, and New York. The response was rapid and transformative. By 1947, dialysis centers were operating on both sides of the Atlantic, each developing their own modifications.

Early Adopters in the United States

One of the most important adopters was Dr. John Merrill at the Peter Bent Brigham Hospital in Boston. Working with Kolff’s machine, Merrill and his team refined the technique, improved patient selection by focusing on those with reversible acute kidney injury, and demonstrated that dialysis could reliably reverse acute uremic syndromes. In 1948, Merrill published a landmark series in the Journal of the American Medical Association showing survival of patients with acute kidney injury who had been treated with the artificial kidney. This work established dialysis as a legitimate medical therapy rather than a desperate experimental measure. Merrill also pioneered the use of blood transfusion during dialysis to reduce the risk of anemia and hypovolemia.

Technical Improvements in the 1950s

The rotating drum kidney had significant drawbacks: it was large (weighing nearly 100 kilograms), required a blood prime, had poor sterility control, and could only be used for a few hours before the cellophane membrane began to clog. Engineers and physicians collaborated to create more practical designs. The twin-coil kidney, developed by Kolff himself in collaboration with the Swedish engineer Nils Alwall, replaced the drum with a stationary coil of cellophane tubing compressed between two surfaces, improving efficiency and reducing size. The coil design increased the surface area for dialysis and allowed for a closed-circuit system, reducing contamination. Meanwhile, the parallel-plate dialyzer, invented by Fredrik Kiil, offered even lower resistance and better blood flow characteristics by sandwiching flat membranes between grooved plastic plates. These innovations made dialysis safer, faster, and more reproducible, setting the stage for its application to chronic kidney disease.

The Dialysis Widens: From Acute to Chronic Treatment

For the first two decades, the artificial kidney was reserved exclusively for acute kidney injury — patients whose kidneys might recover if given temporary support. Chronic kidney disease remained untreatable because the access was temporary and could not be used repeatedly. The only way to connect a patient to the machine was through direct cannulation of an artery and vein, which destroyed that vessel each time it was used. Patients could receive at most a handful of treatments before access sites were exhausted.

The Scribner Shunt: A Portal for Long-Term Access

The game-changing innovation came in 1960 when Dr. Belding Scribner at the University of Washington introduced the Teflon-Silastic shunt. This surgically implanted device connected an artery to a vein externally, providing a durable, reusable access point for hemodialysis. Scribner's breakthrough was realizing that Teflon and Silastic were biocompatible enough to be left in place for weeks or months without triggering blood clots or infection. The first patient treated with Scribner’s shunt was a 39-year-old machinist named Clyde Shields, who lived for another 11 years on thrice-weekly dialysis. Scribner’s success proved that long-term maintenance dialysis was not only possible but could enable patients to return to productive life. The “Scribner shunt” opened the era of chronic hemodialysis. For more on Scribner's contributions, see this historical review.

Birth of the Dialysis Center and the Ethics of Scarcity

With access solved, the need for infrastructure grew rapidly. In 1962, Scribner and his colleagues founded the Seattle Artificial Kidney Center (later the Northwest Kidney Centers), the world’s first outpatient dialysis facility. This center also gave rise to one of medicine’s earliest and most controversial ethics committees — the “God Committee” — which had to decide which patients among many eligible would receive the few available machines. This tragic scarcity highlighted both the life-saving power of dialysis and the profound ethical dilemmas it created. Over the following decades, dialysis expanded dramatically, with the passage of the Medicare End-Stage Renal Disease Program in the United States in 1972, which guaranteed access to treatment for virtually all citizens with kidney failure. This legislation transformed dialysis from a rationed resource into a standard of care, driving rapid expansion of the industry. The National Kidney Foundation offers details on Medicare coverage for ESRD.

Advancements in Dialysis Technology

Since Kolff’s first rotating drum, every component of the artificial kidney has undergone continuous improvement. The modern dialysis machine would be nearly unrecognizable to its inventors, yet the core principle remains the same: blood is cleansed by passage across a semipermeable membrane.

Membranes: From Cellophane to Synthetic Biocompatible Materials

The original cellophane tubing was inconsistent, fragile, and triggered inflammatory responses through complement activation. Modern dialyzers use synthetic membranes made of polysulfone, polyethersulfone, or polyamide. These materials are engineered for precise pore sizes, high hydraulic permeability, and excellent biocompatibility. High-flux dialysis uses membranes with larger pores to remove larger molecular-weight toxins, including beta-2 microglobulin, which accumulates in long-term dialysis patients and contributes to amyloidosis. The shift to synthetic membranes dramatically improved patient outcomes, reducing inflammation and improving survival.

Monitoring and Safety Systems

Early dialysis was risky — air embolism, massive blood loss, and electrolyte disturbances were constant threats. Modern machines incorporate real-time sensors for pressure, temperature, conductivity, and blood leak detection. Automated controls adjust dialysate composition, ultrafiltration rate, and blood flow to maintain stable conditions. Most machines now include redundant safety checks, such as air detectors that clamp the blood line if bubbles are detected, and conductivity cells that ensure dialysate is at the correct sodium concentration. These systems allow for safer, longer, and more personalized treatments, including ultra-slow nocturnal sessions that were impossible in the 1940s.

Home and Nocturnal Dialysis

The push for patient independence has driven the development of smaller, easier-to-use machines. Home hemodialysis, pioneered in the 1960s by patients who learned to cannulate their own shunts, has become increasingly practical with new designs such as the NxStage System One, which is compact enough to fit on a bedside table. Nocturnal dialysis (8–10 hours overnight, 5–6 nights per week) provides superior toxin clearance and fluid management compared to standard three-times-weekly sessions, leading to better blood pressure control, fewer dietary restrictions, and improved survival for patients who can manage the increased treatment time. Home dialysis remains underutilized, but its benefits are increasingly recognized.

Alternative and Emerging Approaches

While hemodialysis remains dominant, other forms of renal replacement therapy have grown in importance. These alternatives offer different trade-offs in terms of convenience, complications, and clinical outcomes.

Peritoneal Dialysis

Peritoneal dialysis uses the body’s own peritoneal membrane as the dialyzer, avoiding the need for external blood circuits. This technique, refined in the 1970s by Dr. Robert Popovich and Dr. Jack Moncrief, offers greater flexibility and can be performed overnight (continuous cycling peritoneal dialysis) or during the day (continuous ambulatory peritoneal dialysis). It represents a crucial alternative for patients who cannot tolerate hemodialysis or desire greater autonomy. Peritoneal dialysis has lower initial costs and allows patients to travel more easily, but carries risks of peritonitis and catheter malfunction. For more about peritoneal dialysis principles, see this NKF overview.

Toward an Implantable Artificial Kidney

The ultimate goal for many researchers is a fully implantable, bioartificial kidney that mimics the natural organ’s functions including metabolic and endocrine activity. Projects such as the Kidney Project at the University of California, San Francisco, are developing microelectromechanical systems (MEMS) combined with living renal tubule cells. These devices aim to be surgically implanted with vascular connections, requiring no external power or consumables. Another approach uses silicon nanopore membranes to replace the glomerular filtration function, with additional cellular components to perform reabsorption and endocrine functions. While still in preclinical testing, these biohybrid approaches represent the most ambitious extension of Kolff’s original vision — a true artificial organ rather than an external machine. The Kidney Project website tracks progress toward clinical trials.

Legacy: Kolff’s Enduring Influence

Willem Kolff did not stop with the artificial kidney. He went on to contribute to the development of the heart-lung machine, the intra-aortic balloon pump, and the first total artificial heart. His approach — relentless experimentation, willingness to improvise with available materials, and deep commitment to patient salvation — set a model for biomedical engineering. In 2002, Life magazine named him one of the 100 most important people of the 20th century. Kolff's rotational principles have been adapted for other blood-contact devices, and his open-source philosophy of sharing his machine designs free of charge accelerated global adoption.

Today, more than 2.5 million people worldwide receive dialysis treatment, with hundreds of thousands of lives sustained each year by technology that traces directly back to Kolff’s rotating drum. The artificial kidney did not merely extend lives — it reshaped the structure of healthcare, creating the fields of nephrology, vascular access surgery, and bioethics as they exist today. The ethics committees that emerged from dialysis scarcity laid the groundwork for modern transplant allocation and resource distribution policies. For a comprehensive overview of the history, this review in the Journal of the American Society of Nephrology provides details.

Conclusion: The Continuing Journey

From a machine built with sausage casings and airplane parts in an occupied Dutch city to billion-dollar global industries and thousands of lives transformed, the history of the artificial kidney is a story of human creativity confronting a fundamental biological limitation. Each improvement — better membranes, safer access, more intelligent monitoring, greater patient independence — builds on the foundation laid by Kolff and his contemporaries. The next frontier, whether it is wearable dialysis, implantable bioartificial organs, or regenerative therapies, will itself be built on the same combination of scientific rigor and audacious hope that drove that first successful treatment in 1943. The work is not finished, but the trajectory is clear: the artificial kidney is one of medicine’s great successes, and its story is still being written.